Top Markets
#1 Islamic Coin Islamic Coin +151.30%
#2 Akedo Akedo +77.68%
#3 Glidr Glidr +51.75%
#4 DOVU DOVU +48.65%
#5 Cross Cross +44.14%
#6 Black Phoenix Black Phoenix +33.98%
#7 Velvet Velvet +25.65%
#8 Cap Cap +25.20%
#9 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.99%
#10 Palladium Network Palladium Network +12.46%
Coin of the day
Islamic Coin Islamic Coin
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Hepion Pharmaceuticals, Inc. Hepion Pharmaceuticals, Inc.

Hepion Pharmaceuticals, Inc.

HEPA
Clasificación en acciones #39072
Hepion Pharmaceuticals, Inc., a U.S.-based biopharmaceutical entity, is... Hepion Pharmaceuticals, Inc., a U.S.-based biopharmaceutical entity, is dedicated to developing therapeutic interventions for chronic hepatic ailments. Central to their efforts is Rencofilstat, a cyclophilin inhibitor that has successfully concluded Phase 2a clinical trials. This compound operates by disrupting multiple pathological pathways implicated in the worsening of liver disease. It is currently progressing through clinical development for non-alcoholic steatohepatitis (NASH) and is additionally being explored in nonclinical research for its potential to reduce liver fibrosis and lessen hepatocellular carcinoma tumor loads in experimental models of NASH. Moreover, Rencofilstat has exhibited antiviral properties against hepatitis B, C, and D viruses through diverse mechanisms. The company, established in 2013 and situated in Edison, New Jersey, rebranded as Hepion Pharmaceuticals, Inc. in July 2019, having previously operated as ContraVir Pharmaceuticals, Inc.
Precio por acción
$0.0568
Última sincronización: 2026-08-13
Capitalización bursátil
$661.36K
Cambio (1 día)
11.37%
Cambio (1 año)
-5.33%
País
US
Comercio Hepion Pharmaceuticals, Inc. (HEPA)

Categoría

Healthcare
Precio HEPA con Capital del mercado a B
Hepion Pharmaceuticals, Inc. Hepion Pharmaceuticals, Inc.
HEPA
$0.0568
Capitalización de mercado de Hepion Pharmaceuticals, Inc.(HEPA)
Capitalización bursátil: $661.36K
A fecha de August 2026, Hepion Pharmaceuticals, Inc. tiene una capitalización de mercado de $661.36K. Esto convierte a Hepion Pharmaceuticals, Inc. en la 39072nd empresa más valiosa del mundo por capitalización bursátil, según nuestros datos. La capitalización bursátil es el valor total de mercado de las acciones en circulación de una empresa que cotiza en bolsa y se utiliza comúnmente para medir su valor.
Historial de capitalización de mercado de Hepion Pharmaceuticals, Inc. desde 2014 hasta 2026
HEPA en comparación con los más populares 5 títulos stocks
Precio por HEPA Activo B Capital del mercado en B Resultados
Hepion Pharmaceuticals, Inc. Hepion Pharmaceuticals, Inc.
$469,742 $661.36K
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.470T +827,009,900.33%
Hepion Pharmaceuticals, Inc. Hepion Pharmaceuticals, Inc.
$383,647 $661.36K
Apple Inc. Apple Inc.
AAPL
$4.467T +675,434,042.20%
Hepion Pharmaceuticals, Inc. Hepion Pharmaceuticals, Inc.
$358,510 $661.36K
Alphabet Inc. Alphabet Inc.
GOOG
$4.174T +631,179,244.65%
Hepion Pharmaceuticals, Inc. Hepion Pharmaceuticals, Inc.
$317,775 $661.36K
Microsoft Corporation Microsoft Corporation
MSFT
$3.700T +559,462,337.44%
Hepion Pharmaceuticals, Inc. Hepion Pharmaceuticals, Inc.
$245,140 $661.36K
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.854T +431,584,807.66%